Literature DB >> 9744975

Doxorubicin-induced cardiomyopathy.

P K Singal1, N Iliskovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9744975     DOI： 10.1056/NEJM199809243391307

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  450 in total

Review 1.  Cardiotoxicity of doxorubicin and other anthracycline derivatives.

Authors:  D Jain
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

Review 2.  Treating cancer patients. Practical monitoring and management of therapy-related complications.

Authors:  M Brigden; M McKenzie
Journal:  Can Fam Physician       Date:  2000-11       Impact factor: 3.275

Review 3.  Transition metals and mitochondrial metabolism in the heart.

Authors:  Amy K Rines; Hossein Ardehali
Journal:  J Mol Cell Cardiol       Date:  2012-06-02       Impact factor: 5.000

4.  Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes.

Authors:  Ana Ludke; Anita K Sharma; Ashim K Bagchi; Pawan K Singal
Journal:  Mol Cell Biochem       Date:  2011-09-22       Impact factor: 3.396

5.  Noninvasive detection of cell death: from tracking epitaphs to counting coffins.

Authors:  Jagat Narula; Barry L Zaret
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

Review 6.  Drug-induced mitochondrial dysfunction and cardiotoxicity.

Authors:  Zoltán V Varga; Peter Ferdinandy; Lucas Liaudet; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

Review 7.  Doxorubicin-induced apoptosis: implications in cardiotoxicity.

Authors:  B Kalyanaraman; Joy Joseph; Shashi Kalivendi; Suwei Wang; Eugene Konorev; Srigiridhar Kotamraju
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

8.  Mrp1 localization and function in cardiac mitochondria after doxorubicin.

Authors:  Paiboon Jungsuwadee; Ramaneeya Nithipongvanitch; Yumin Chen; Terry D Oberley; D Allan Butterfield; Daret K St Clair; Mary Vore
Journal:  Mol Pharmacol       Date:  2009-02-20       Impact factor: 4.436

Review 9.  Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.

Authors:  Jean Domercant; Nichole Polin; Eiman Jahangir
Journal:  Ochsner J       Date:  2016

Review 10.  Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review.

Authors:  Sakshi Jasra; Jesus Anampa
Journal:  Curr Treat Options Oncol       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.